Elon Musk's brain implant company Neuralink says the FDA has approved human trials

Neuralink has announced that the U.S. Food and Drug Administration (FDA) has approved the launch of its first clinical study in humans.

"We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!" Neuralink's official Twitter account wrote on Thursday.(opens in a new tab) "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."

The neurotechnology company isn't recruiting test subjects...